fenclonine has been researched along with Carcinoma 256, Walker in 1 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chance, WT | 1 |
| Von Meyenfeldt, M | 1 |
| Fischer, JE | 1 |
1 other study available for fenclonine and Carcinoma 256, Walker
| Article | Year |
|---|---|
Delay of cancer anorexia following intraventricular injection of para-chlorophenylalanine.
Topics: Animals; Brain; Carcinoma 256, Walker; Eating; Female; Fenclonine; Hydroxyindoleacetic Acid; Injecti | 1982 |